Cargando…
Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576059/ https://www.ncbi.nlm.nih.gov/pubmed/34763124 http://dx.doi.org/10.1016/j.jaip.2021.08.044 |
_version_ | 1784595806883414016 |
---|---|
author | Leef, Chelsea Horton, Codi Lee, Tricia Lee, Gerald Tison, Katherine Vickery, Brian P. |
author_facet | Leef, Chelsea Horton, Codi Lee, Tricia Lee, Gerald Tison, Katherine Vickery, Brian P. |
author_sort | Leef, Chelsea |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8576059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85760592021-11-09 Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 Leef, Chelsea Horton, Codi Lee, Tricia Lee, Gerald Tison, Katherine Vickery, Brian P. J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-01 2021-11-09 /pmc/articles/PMC8576059/ /pubmed/34763124 http://dx.doi.org/10.1016/j.jaip.2021.08.044 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Communications Leef, Chelsea Horton, Codi Lee, Tricia Lee, Gerald Tison, Katherine Vickery, Brian P. Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 |
title | Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 |
title_full | Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 |
title_fullStr | Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 |
title_full_unstemmed | Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 |
title_short | Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 |
title_sort | exploring barriers to commercial peanut oral immunotherapy treatment during covid-19 |
topic | Clinical Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576059/ https://www.ncbi.nlm.nih.gov/pubmed/34763124 http://dx.doi.org/10.1016/j.jaip.2021.08.044 |
work_keys_str_mv | AT leefchelsea exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19 AT hortoncodi exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19 AT leetricia exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19 AT leegerald exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19 AT tisonkatherine exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19 AT vickerybrianp exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19 |